HOME >> BIOLOGY >> NEWS
Natural resistance of pigment cells to sunlight may make deadly skin cancer tough to treat

screen cells, the melanocytes, are continuously bombarded by ultraviolet solar radiation as they generate pigment which protects underlying skin cells. Ordinarily, the melanocytes would become damaged from the radiation and apoptosis may be initiated, unless there were some countervailing force. And there is: During human evolution, melanocytes appear to have acquired at least one such mechanism that neutralizes apoptosis and enables the cells to survive. The main players in this apoptosis-blocking game are MITF and another gene with which it interacts, BCL2.

The MITF gene, dubbed by scientists as the master melanocyte regulator, is found in melanocytes and is critical for their proper development and their long-term survival. In addition MITF is thought to play a key role in production of pigment by these cells. BCL2 is a cell-death suppressor, many of whose actions were discovered by Dana-Farber researcher Stanley J. Korsmeyer, MD.

When either the MITF or BCL2 gene is mutated or missing, the whiskers and fur of mice turn from black to gray or white because melanocytes have died. A mutant MITF gene is involved in a human genetic disorder that causes, among other abnormalities, locks of white hair from birth.

The investigators used microarrays, or DNA chips, to determine what genes are turned on when the MITF gene is active, i.e., what genes are targets of MITF within normal melanocytes. The microarray experiments showed that the protein produced by MITF links up with the BCL2 gene both in normal melanocytes and in melanoma cells, increasing the amount of BCL2 protein being made, and activating cell survival.

McGill and others in the Fisher lab also inhibited the activity of MITF in melanocytes and melanoma cells by infecting them with genetically engineered viruses. When the viruses blocked the action of MITF, the cells died. By the same token, the researchers could artificially rev up the activity of BCL2 in MITF-inhibited melano
'"/>

Contact: Bill Schalaler
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
13-Jun-2002


Page: 1 2 3

Related biology news :

1. Natural mineral locks up carbon dioxide
2. Naturalists of the Isthmus of Panama
3. Natural selection at work in genetic variation to taste
4. Natural, man-made mix promises biggest landscape plant growth
5. Natural enemies help scientists untangle tropical forest food webs
6. Natural killer cellers are made, not born
7. Natural selection in a nutshell
8. Natural fat compound may be basis for new class of drugs targeting obesity
9. Natural hormone could reverse heart damage
10. New biography details adventures of Fritz Muller, A Naturalist in Brazil
11. Natural selections fingerprint identified on fruit fly evolution

Post Your Comments:
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
(Date:7/29/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... optimized Erk inhibitor molecule for development, thus achieving ... new class of potential cancer therapies. ... for therapeutic intervention in cancer. Recently approved compounds ... B-Raf and Mek inhibitors. Erk inhibitors may be ...
(Date:7/29/2015)... ... July 29, 2015 , ... Rainbow Scientific, Inc. (RSI), a ... availability of BI’s line of human mesenchymal stem cell (hMSC) differentiation media, ... offer a complete system for multipotency evaluation of hMSCs and reliable induction of ...
(Date:7/28/2015)... ... ... 530 sample changer for vials can be used with Anton Paar density meters, viscometers ... mPas (internal air) up to 36,000 (external air) – and can process up to 71 ... is its removable magazine, which is easily lifted off its hub and carried by hand ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2
Cached News: